Improving psychiatric drug therapy. a matter of dosage and choice
Cole, J.O.; Stotsky, B.A.
Geriatrics 29(6): 74-78
1974
ISSN/ISBN: 0016-867X PMID: 4364716 Document Number: 73217
Document emailed within 1 workday
Related Documents
Henry, B.W.; Overall, J.E.; Woodward, J.A. 1976: Actuarial justification for choice of drug treatment for psychiatric patients Diseases of the Nervous System 37(10): 555-557Gladtke, E. 1981: Current problems in drug therapy in children. Drug interactions, age-dependent changes in pharmacokinetic data, recommendations for dosage Die Medizinische Welt 32(7): 219-224
Menninger, H.; Burkhardt, H. 1983: Long-term drug therapy in inflammatory rheumatic diseases using chronic polyarthritis as an example. 2. Basic principles of long-term drug therapy: choice of optimal therapeutic agents Fortschritte der Medizin 101(14): 639-645
Brazier, J.L.; Renaud, H.; Belkahia, C. 1981: Importance of drug dosage in pediatric therapy La Tunisie Medicale 59(4): 257-264
Smulevich, A.B.; Vorob'ev, V.I.; Tarasova, T.P.; Abrosimov, A.I. 1987: Psychotropic drug therapy using maintenance dosage pumps Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 87(6): 888-893
Zhiliaev, E.V.; Glazunov, A.V.; Koroba, G.S. 1994: Approaches to the personal antianginal therapy. can we consider nitrosorbide as a drug of choice? Klinicheskaia Meditsina 72(4): 62-64
Nakamura, H. 1988: Regression and therapy of atherosclerosis: drug therapy of atherosclerosis viewed from serum lipoprotein analysis--reality of application, choice and administration of anticholesteremic agents Nihon Rinsho. Japanese Journal of Clinical Medicine 46(3): 710-716
Fraser, G.E.; Shavlik, D.J. 2001: Ten years of life: Is it a matter of choice? Archives of Internal Medicine 161(13): 1645-1652
Adasheva, T.V.; Samorukova, E.I.; Zadionchenko, V.S.; Nesterenko, O.I. 2013: What is the optimal choice of antihypertensive therapy based on: the class-specific effects or special properties of a drug? Terapevticheskii Arkhiv 85(9): 102-106
Soen, S. 2007: First choice drug for treatment of osteoporosis and the strategic points for choice of drugs Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 9): 325-328
Mohr, F.; Bender, W.; Hubmann, W.; Mäsel, K.; Pior, R. 1992: Drug management and therapy resistance. A cross-sectional study of schizophrenic patients in a large psychiatric hospital Psychiatrische Praxis 19(4): 108-113
Saleem, S.; Fikree, F.F. 2005: The quest for small family size among Pakistani women--is voluntary termination of pregnancy a matter of choice or necessity? Jpma. Journal of the Pakistan Medical Association 55(7): 288-291
Levi-Minzi, A.; Riva, M. 1988: Clotiazepam in psychiatric practice. Study with a daily high dosage per os Minerva Psichiatrica 29(3): 161-163
Whicher, C.A.; Shah, R.; Gleeson, H.; Vaughan, L.; Albon, L. 2016: Improving acute care for adolescents and young adults on medical admission units: the interventions that matter Acute Medicine 15(3): 157-160
Krausz, M. 1995: Drug dependence in psychiatric practice--new trends in therapy of dependence Psychiatrische Praxis 22(5): 177-178
Wahlgren, C.-F. 2013: Propranolol first choice in infantile hemangiomas. Large randomized trials are needed to determine the dosage and duration of treatment Lakartidningen 110(19-20): 938-939
Marr, M.A.; Djuric, P.E.; Ritschel, W.A.; Garver, D.L. 1983: Prediction of lithium carbonate dosage in psychiatric inpatients using the repeated one-point method Clinical Pharmacy 2(3): 243-248
Leonskaia, G.I. 1984: Dosage choice for studying the embryotoxic and teratogenic action of chemical substances for setting their permissible levels in reservoir water Vrachebnoe Delo 2: 103-106
Hahn, M.; Braus, D.F. 2012: Psychiatric polypharmacy: hazard through drug-drug-interaction and possibilities for prevention Versicherungsmedizin 64(3): 127-131
Ettner, S.L.; Hermann, R.C. 1997: Provider specialty choice among Medicare beneficiaries treated for psychiatric disorders Health Care Financing Review 18(3): 43-59